The Lancet began as an independent, international weekly general medical journal founded in 1823 by Thomas Wakley. Since its first issue (Oct 5, 1823), the journal has strived to make science widely available so that medicine can serve and transform society, and positively impact the lives of people. Over the past two centuries, The Lancet has sought to address urgent topics in our society, initiate debate, put science into context, and influence decision makers around the world. The Lancet has evolved as a family of journals but retains at its core the belief that medicine must serve society, that knowledge must transform society, that the best science must lead to better lives. The Lancet is a trade mark of RELX Intellectual Properties SA, used under license.
External link for The Lancet
125 London Wall
London, EC2Y 5AS, GB
Register to join our upcoming Lancet Webinar and hear from our Commission authors as they discuss the critical issues facing global access to radiotherapy and promising developments in the field of theranostics. Register now: https://hubs.li/Q02SjL4S0 🗓️ Nov 12, 13:30 GMT/08:30 EST
This content isn’t available here
Access this content and more in the LinkedIn app
Self-harm remains neglected worldwide, with at least 14 million episodes yearly. This figure is likely an underestimate. People who self-harm often do not present to health services, and surveillance systems are poor. In addition, self-harm with suicidal intent is still a criminal offense in some countries. Self-harm is a behaviour shaped by society, culture, and individual factors. It is not a psychiatric diagnosis. “Self-harm signals deeper distress and affects millions globally, especially young people,” says Professor Paul Moran, lead author of the Commission report. 12 key recommendations for action are outlined (see infographic panels below). This #WorldMentalHealthDay, read the Commission report and linked content 👉 https://hubs.li/Q02SjGVZ0
📣 Save the date for our upcoming Lancet Webinar! 📣 The prevalence of Parkinson’s disease has doubled in the past 25 years. Our upcoming webinar explores how genetic discoveries in Parkinson’s disease have influenced clinical practice and can lead to new diagnostic criteria. Register to join: https://hubs.li/Q02R2Tzt0 🗓️ Oct 22, 2024 🕘 14:00 BST / 09:00 EDT
The Lancet reposted this
Do you know anyone who would be interested in the latest evidence on the connections between health and climate change? Tag them in the comments below 👇 We are publishing the Lancet Countdown 2024 Report on Health and Climate Change in The Lancet on 30 October, days before the UN’s annual climate change summit, COP29. Be the first to hear the findings and analysis from experts at our launch event! Register now: https://lnkd.in/exX2d9_k
🚨 Submission alert - we’re inviting entries to our annual essay competition, the Wakley Prize. With less than two weeks to go, put pen to paper and share your ideas on centring care in medicine. More here: https://hubs.li/Q02Sjj0g0
Explore the positive role cities can take to reduce CO2 emissions and improve our health in response to the climate crisis. During our annual International Health Lecture, together with The Academy of Medical Sciences, keynote speaker Mark J Nieuwenhuijsen will discuss the climate impact of cities, their effect on our health, and how new urban models can promote more climate-neutral, liveable, and healthy cities. Register now to attend our hybrid event on October 17, 2024: https://hubs.li/Q02NmRyy0
Radiotherapy is a crucial component of cancer care, yet global access to services, as well as the promising field of theranostics, remains a major problem. An estimated 50–70% of all patients with cancer worldwide need radiotherapy, with more than 50% of this population residing in low-income and middle-income countries (LMICs). “Although [there] are many challenges, better coordination, collaboration, and planning can achieve improved and equitable access for patients to radiotherapy and theranostics, leading to improved outcomes” say authors of a new Commission in The Lancet Oncology. Action and investment are needed to enhance access worldwide to reduce the burden of cancer, including: – Developing and adopting global standards for infrastructure and optimal deployment – Aligning human resources with the needs of patients – Ensuring the global availability of radioisotopes for theranostics Find out more 👉 https://hubs.li/Q02Rsstc0 Figure: Global availability of radiotherapy machines per million inhabitants
Endometriosis: addressing the roots of slow progress Governments need to formulate plans that not only include measurable targets and interventions across the care pathway but also address the need to change the culture around women, pain, and periods. Read this week’s issue of The Lancet ▶️ https://hubs.li/Q02S9GXV0
Yesterday, our Series authors discussed the urgent need for reforming South Asia’s primary health care system as part of our Series launch webinar. Couldn’t attend the webinar live? You can now watch our Series launch on-demand at your convenience: https://hubs.li/Q02NX67W0
Transplantation often represents the only life-saving treatment available for end-stage organ failure and can transform the lives of people who are dependent on burdensome technologies, such as dialysis. However, there is a worldwide organ shortage. Data suggests only 10% of global transplant demand is being met. In The Lancet’s new issue, an Editorial explores the challenges in organ donation and lessons from the Spanish model. Access here: bit.ly/4dsb55x Alt text: Cover of The Lancet, Sept 28 issue. The quote reads, “The decision to donate organs raises deep questions...The Spanish model demonstrates the central importance of trust. When a well-designed and resourced system is in place, people respond with solidarity.”